Drug Shortage Report for INTRALIPID 20%
Report ID | 145481 |
Drug Identification Number | 02065673 |
Brand name | INTRALIPID 20% |
Common or Proper name | Intralipid 20% (Lipid injectable emulsion) 500 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SOYBEAN OIL |
Strength(s) | 20% |
Dosage form(s) | EMULSION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500 mL |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-09-07 |
Actual start date | 2021-09-07 |
Estimated end date | 2021-10-21 |
Actual end date | 2021-10-21 |
Shortage status | Resolved |
Updated date | 2021-10-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-09-10 | English | Compare |
v2 | 2021-09-10 | French | Compare |
v3 | 2021-10-07 | English | Compare |
v4 | 2021-10-07 | French | Compare |
v5 | 2021-10-21 | English | Compare |
v6 | 2021-10-21 | French | Compare |
v7 | 2021-10-22 | English | Compare |
Showing 1 to 7 of 7